TY - T1的常规调查< em >结核分枝杆菌< / em >隔离了院内传播JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.01888 -2019欧元SP - 1901888 AU Genestet夏洛特AU -帕,拉斐尔盟——Pichat凯瑟琳盟——Berland jean - luc AU - Jacomo,薇罗尼卡非盟- Carret,杰拉德AU - Fredenucci,伊莎贝尔盟——Hodille伊丽莎白盟——Rasigade让-菲利普•盟——Boisset Sandrine盟——Carricajo安妮AU -莉娜,杰拉德盟——Ronnaux-Baron创作的非盟- Mornex,让非盟- Grando,杰奎琳盟——Senechal Agathe AU -阿德,佛罗伦萨盟——Dumitrescu Oana A2 -,Y1 - 2019/01/01 UR - //www.qdcxjkg.com/content/early/2019/11/19/13993003.01888 - 2019. -抽象N2 -控制结核分枝杆菌(Mtb)传输高收入卫生保健机构和低结核病(TB)仍然是一个流行国家公共卫生优先考虑到全球结核分枝杆菌的不断变化流行病学。尽管欧洲是[1]发病率较低的地区，但不稳定人口和移民人口中的结核负担促成了这一不断演变的局面，消除结核病[2]行动框架对此作出了处理。作为国家卫生保健系统的核心，三级保健医院既管理更容易感染结核病的患者，也管理复杂和/或晚期结核病患者。结核病控制的关键措施依赖于使病例联系和传播链识别成为可能，这往往得到分子调查工具的支持[3,4]。这篇手稿最近已被欧洲呼吸杂志接受出版。它是在我们的生产团队进行编辑和排版之前，以其公认的形式在这里出版的。在这些生产过程完成后，作者已经批准的结果证明，文章将移动到最新一期的ERJ在线。请打开或下载PDF格式以浏览本文。利益冲突:Genestet博士报告了在研究进行期间，法国国家研究机构(ANR)运营的“投资d'Avenir”(ANR-11- idex -0007)项目中，来自里昂大学LABEX ECOFECT (ANR-11- labx -0048)的拨款。利益冲突:帕雷特医生没有什么可透露的。Conflict of interest: Mrs. Pichat has nothing to disclose.Conflict of interest: Mr. Berland has nothing to disclose.Conflict of interest: Dr. Jacomo has nothing to disclose.Conflict of interest: Dr. Carret has nothing to disclose.Conflict of interest: Dr. Fredenucci has nothing to disclose.Conflict of interest: Dr. Hodille has nothing to disclose.Conflict of interest: Dr. Rasigade has nothing to disclose.Conflict of interest: Dr. Boisset has nothing to disclose.Conflict of interest: Dr. Carricajo has nothing to disclose.Conflict of interest: Pr. Lina has nothing to disclose.Conflict of interest: Dr. Ronnaux-Baron has nothing to disclose.Conflict of interest: Dr. Mornex has nothing to disclose.Conflict of interest: Dr. Grando has nothing to disclose.Conflict of interest: Dr. Sénéchal has nothing to disclose.Conflict of interest: Pr. Ader has nothing to disclose.Conflict of interest: Dr. Dumitrescu has nothing to disclose. ER -